Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Efficacy and safety of anakinra for undifferentiated autoinflammatory diseases in children: a retrospective case review.

Garg S, Wynne K, Omoyinmi E, Eleftheriou D, Brogan P.

Rheumatol Adv Pract. 2019 Feb 12;3(1):rkz004. doi: 10.1093/rap/rkz004. eCollection 2019.

2.

Fucosidosis mimicking juvenile idiopathic arthritis.

Wynne E, Wynne K, Cleary M, Brogan PA.

Rheumatol Adv Pract. 2018 Oct 3;2(2):rky040. doi: 10.1093/rap/rky040. eCollection 2018. No abstract available.

3.

British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature.

Rowczenio DM, Youngstein T, Trojer H, Omoyinmi E, Baginska A, Brogan P, Papadopoulou C, Rezk T, Hawkins PN, Lachmann HJ.

Rheumatology (Oxford). 2019 Aug 5. pii: kez334. doi: 10.1093/rheumatology/kez334. [Epub ahead of print]

PMID:
31384939
4.

Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2).

Clarke K, Campbell C, Omoyinmi E, Hong Y, Al Obaidi M, Sebire N, Brogan PA.

Pediatr Rheumatol Online J. 2019 Jul 10;17(1):39. doi: 10.1186/s12969-019-0334-5.

5.

Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome.

Elmi AA, Wynne K, Cheng IL, Eleftheriou D, Lachmann HJ, Hawkins PN, Brogan P.

Pediatr Rheumatol Online J. 2019 Jul 8;17(1):36. doi: 10.1186/s12969-019-0335-4.

6.

Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases.

Ter Haar NM, Eijkelboom C, Cantarini L, Papa R, Brogan PA, Kone-Paut I, Modesto C, Hofer M, Iagaru N, Fingerhutová S, Insalaco A, Licciardi F, Uziel Y, Jelusic M, Nikishina I, Nielsen S, Papadopoulou-Alataki E, Olivieri AN, Cimaz R, Susic G, Stanevica V, van Gijn M, Vitale A, Ruperto N, Frenkel J, Gattorno M; Eurofever registry and the Pediatric Rheumatology International Trial Organization (PRINTO).

Ann Rheum Dis. 2019 Oct;78(10):1405-1411. doi: 10.1136/annrheumdis-2018-214472. Epub 2019 Jul 5.

PMID:
31278138
7.

Inflammatory Arthritis as a Possible Feature of Coffin-Siris Syndrome.

Melo Gomes S, Dias C, Omoyinmi E, Compeyrot-Lacassagne S, Klein N, Sebire NJ, Brogan P.

Pediatrics. 2019 Jul;144(1). pii: e20181741. doi: 10.1542/peds.2018-1741.

PMID:
31243159
8.

Janus kinase 1/2 inhibition for the treatment of autoinflammation associated with heterozygous TNFAIP3 mutation.

Mulhern CM, Hong Y, Omoyinmi E, Jacques TS, D'Arco F, Hemingway C, Brogan PA, Eleftheriou D.

J Allergy Clin Immunol. 2019 Sep;144(3):863-866.e5. doi: 10.1016/j.jaci.2019.05.026. Epub 2019 Jun 5. No abstract available.

9.

Comparing the clinical profile of adults and children with Behçet's syndrome in the UK.

Makmur EL, Myers SH, Hanns L, Haskard DO, Brogan P, Ambrose N.

Clin Exp Rheumatol. 2019 May 30. [Epub ahead of print]

PMID:
31172922
10.

Rapid and Sustained Long-Term Efficacy and Safety of Canakinumab in Patients With Cryopyrin-Associated Periodic Syndrome Ages Five Years and Younger.

Brogan PA, Hofer M, Kuemmerle-Deschner JB, Koné-Paut I, Roesler J, Kallinich T, Horneff G, Calvo Penadés I, Sevilla-Perez B, Goffin L, Lauwerys BR, Lachmann HJ, Uziel Y, Wei X, Laxer RM.

Arthritis Rheumatol. 2019 Jun 4. doi: 10.1002/art.41004. [Epub ahead of print]

PMID:
31161734
11.

Pharmacodynamics of rituximab on B lymphocytes in paediatric patients with autoimmune diseases.

Pan S, Yu H, Surti A, Cheng I, Marks SD, Brogan PA, Eleftheriou D, Standing JF.

Br J Clin Pharmacol. 2019 Aug;85(8):1790-1797. doi: 10.1111/bcp.13970. Epub 2019 Jun 20.

12.

Classification criteria for autoinflammatory recurrent fevers.

Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, Anton J, Arostegui JI, Barron K, Ben-Cherit E, Brogan PA, Cantarini L, Ceccherini I, De Benedetti F, Dedeoglu F, Demirkaya E, Frenkel J, Goldbach-Mansky R, Gul A, Hentgen V, Hoffman H, Kallinich T, Kone-Paut I, Kuemmerle-Deschner J, Lachmann HJ, Laxer RM, Livneh A, Obici L, Ozen S, Rowczenio D, Russo R, Shinar Y, Simon A, Toplak N, Touitou I, Uziel Y, van Gijn M, Foell D, Garassino C, Kastner D, Martini A, Sormani MP, Ruperto N; Eurofever Registry and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Ann Rheum Dis. 2019 Aug;78(8):1025-1032. doi: 10.1136/annrheumdis-2019-215048. Epub 2019 Apr 24. Review.

PMID:
31018962
13.

European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.

Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.

Rheumatology (Oxford). 2019 Sep 1;58(9):1607-1616. doi: 10.1093/rheumatology/kez041.

PMID:
30879080
14.

Monogenic mimics of Behçet's disease in the young.

Papadopoulou C, Omoyinmi E, Standing A, Pain CE, Booth C, D'Arco F, Gilmour K, Buckland M, Eleftheriou D, Brogan PA.

Rheumatology (Oxford). 2019 Jul 1;58(7):1227-1238. doi: 10.1093/rheumatology/key445.

PMID:
30715505
15.

Janus kinase 1/2 inhibition with baricitinib in the treatment of juvenile dermatomyositis.

Papadopoulou C, Hong Y, Omoyinmi E, Brogan PA, Eleftheriou D.

Brain. 2019 Mar 1;142(3):e8. doi: 10.1093/brain/awz005. No abstract available.

16.

The European network for care of children with paediatric rheumatic diseases: care across borders.

Dolezalova P, Anton J, Avcin T, Beresford MW, Brogan PA, Constantin T, Egert Y, Foeldvari I, Foster HE, Hentgen V, Kone-Paut I, Kuemmerle-Deschner JB, Lahdenne P, Magnusson B, Martini A, McCann L, Minden K, Ozen S, Schoemaker C, Quartier P, Ravelli A, Rumba-Rozenfelde I, Ruperto N, Vastert S, Wouters C, Zulian F, Wulffraat NM.

Rheumatology (Oxford). 2019 Jul 1;58(7):1188-1195. doi: 10.1093/rheumatology/key439.

PMID:
30668879
17.

Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.

Jones RB, Hiemstra TF, Ballarin J, Blockmans DE, Brogan P, Bruchfeld A, Cid MC, Dahlsveen K, de Zoysa J, Espigol-Frigolé G, Lanyon P, Peh CA, Tesar V, Vaglio A, Walsh M, Walsh D, Walters G, Harper L, Jayne D; European Vasculitis Study Group (EUVAS).

Ann Rheum Dis. 2019 Mar;78(3):399-405. doi: 10.1136/annrheumdis-2018-214245. Epub 2019 Jan 5.

PMID:
30612116
18.

European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative.

de Graeff N, Groot N, Brogan P, Ozen S, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.

Rheumatology (Oxford). 2019 Apr 1;58(4):656-671. doi: 10.1093/rheumatology/key322.

PMID:
30535249
19.

European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative.

de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Brogan P, Beresford MW.

Rheumatology (Oxford). 2019 Apr 1;58(4):672-682. doi: 10.1093/rheumatology/key344.

PMID:
30535127
20.

Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in C3.

Omoyinmi E, Mohamoud I, Gilmour K, Brogan PA, Eleftheriou D.

Front Immunol. 2018 Nov 1;9:2524. doi: 10.3389/fimmu.2018.02524. eCollection 2018.

21.

Autoinflammation due to homozygous S208 MEFV mutation.

Hong Y, Standing ASI, Nanthapisal S, Sebire N, Jolles S, Omoyinmi E, Verstegen RH, Brogan PA, Eleftheriou D.

Ann Rheum Dis. 2019 Apr;78(4):571-573. doi: 10.1136/annrheumdis-2018-214102. Epub 2018 Oct 24. No abstract available.

22.

Successful use of ofatumumab in two cases of early-onset juvenile SLE with thrombocytopenia caused by a mutation in protein kinase C δ.

Lei L, Muhammad S, Al-Obaidi M, Sebire N, Cheng IL, Eleftheriou D, Brogan P.

Pediatr Rheumatol Online J. 2018 Sep 26;16(1):61. doi: 10.1186/s12969-018-0278-1.

23.

Tocilizumab for the Treatment of Mevalonate Kinase Deficiency.

Rafiq NK, Lachmann H, Joensen F, Herlin T, Brogan PA.

Case Rep Pediatr. 2018 Aug 26;2018:3514645. doi: 10.1155/2018/3514645. eCollection 2018.

24.

Patient healthcare passports in community specialist palliative care: a mixed methods study.

White C, Sproule J, Brogan P, Watson M.

BMJ Support Palliat Care. 2018 Aug 18. pii: bmjspcare-2018-001589. doi: 10.1136/bmjspcare-2018-001589. [Epub ahead of print]

PMID:
30121580
25.

Kawasaki disease: a prospective population survey in the UK and Ireland from 2013 to 2015.

Tulloh RMR, Mayon-White R, Harnden A, Ramanan AV, Tizard EJ, Shingadia D, Michie CA, Lynn RM, Levin M, Franklin OD, Craggs P, Davidson S, Stirzaker R, Danson M, Brogan PA.

Arch Dis Child. 2019 Jul;104(7):640-646. doi: 10.1136/archdischild-2018-315087. Epub 2018 Aug 13.

PMID:
30104394
26.

In silico validation of the Autoinflammatory Disease Damage Index.

Ter Haar NM, van Delft ALJ, Annink KV, van Stel H, Al-Mayouf SM, Amaryan G, Anton J, Barron KS, Benseler S, Brogan PA, Cantarini L, Cattalini M, Cochino AV, de Benedetti F, Dedeoglu F, de Jesus AA, Demirkaya E, Dolezalova P, Durrant KL, Fabio G, Gallizzi R, Goldbach-Mansky R, Hachulla E, Hentgen V, Herlin T, Hofer M, Hoffman HM, Insalaco A, Jansson AF, Kallinich T, Kone-Paut I, Kozlova A, Kuemmerle-Deschner JB, Lachmann HJ, Laxer RM, Martini A, Nielsen S, Nikishina I, Ombrello AK, Özen S, Papadopoulou-Alataki E, Quartier P, Rigante D, Russo R, Simon A, Trachana M, Uziel Y, Ravelli A, Schulert G, Gattorno M, Frenkel J.

Ann Rheum Dis. 2018 Nov;77(11):1599-1605. doi: 10.1136/annrheumdis-2018-213725. Epub 2018 Aug 4.

PMID:
30077992
27.

Genetic interferonopathies: An overview.

Eleftheriou D, Brogan PA.

Best Pract Res Clin Rheumatol. 2017 Aug;31(4):441-459. doi: 10.1016/j.berh.2017.12.002. Epub 2018 Feb 1. Review.

PMID:
29773266
28.

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.

De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, Koné-Paut I, Lachmann HJ, Ozen S, Simon A, Zeft A, Calvo Penades I, Moutschen M, Quartier P, Kasapcopur O, Shcherbina A, Hofer M, Hashkes PJ, Van der Hilst J, Hara R, Bujan-Rivas S, Constantin T, Gul A, Livneh A, Brogan P, Cattalini M, Obici L, Lheritier K, Speziale A, Junge G.

N Engl J Med. 2018 May 17;378(20):1908-1919. doi: 10.1056/NEJMoa1706314.

29.

Cutaneous Vasculitis and Recurrent Infection Caused by Deficiency in Complement Factor I.

Nanthapisal S, Eleftheriou D, Gilmour K, Leone V, Ramnath R, Omoyinmi E, Hong Y, Klein N, Brogan PA.

Front Immunol. 2018 Apr 11;9:735. doi: 10.3389/fimmu.2018.00735. eCollection 2018.

30.

An international delphi survey for the definition of the variables for the development of new classification criteria for periodic fever aphtous stomatitis pharingitis cervical adenitis (PFAPA).

Vanoni F, Federici S, Antón J, Barron KS, Brogan P, De Benedetti F, Dedeoglu F, Demirkaya E, Hentgen V, Kallinich T, Laxer R, Russo R, Toplak N, Uziel Y, Martini A, Ruperto N, Gattorno M, Hofer M; for Eurofever and the Paediatric Rheumatology International Trials Organisation (PRINTO).

Pediatr Rheumatol Online J. 2018 Apr 18;16(1):27. doi: 10.1186/s12969-018-0246-9.

31.

JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.

Sanchez GAM, Reinhardt A, Ramsey S, Wittkowski H, Hashkes PJ, Berkun Y, Schalm S, Murias S, Dare JA, Brown D, Stone DL, Gao L, Klausmeier T, Foell D, de Jesus AA, Chapelle DC, Kim H, Dill S, Colbert RA, Failla L, Kost B, O'Brien M, Reynolds JC, Folio LR, Calvo KR, Paul SM, Weir N, Brofferio A, Soldatos A, Biancotto A, Cowen EW, Digiovanna JJ, Gadina M, Lipton AJ, Hadigan C, Holland SM, Fontana J, Alawad AS, Brown RJ, Rother KI, Heller T, Brooks KM, Kumar P, Brooks SR, Waldman M, Singh HK, Nickeleit V, Silk M, Prakash A, Janes JM, Ozen S, Wakim PG, Brogan PA, Macias WL, Goldbach-Mansky R.

J Clin Invest. 2018 Jul 2;128(7):3041-3052. doi: 10.1172/JCI98814. Epub 2018 Jun 11.

32.

Allogeneic hematopoietic stem cell transplantation for severe, refractory juvenile idiopathic arthritis.

M F Silva J, Ladomenou F, Carpenter B, Chandra S, Sedlacek P, Formankova R, Grandage V, Friswell M, Cant AJ, Nademi Z, Slatter MA, Gennery AR, Hambleton S, Flood TJ, Lucchini G, Chiesa R, Rao K, Amrolia PJ, Brogan P, Wedderburn LR, Glanville JM, Hough R, Marsh R, Abinun M, Veys P.

Blood Adv. 2018 Apr 10;2(7):777-786. doi: 10.1182/bloodadvances.2017014449.

33.

Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target.

Apps JR, Carreno G, Gonzalez-Meljem JM, Haston S, Guiho R, Cooper JE, Manshaei S, Jani N, Hölsken A, Pettorini B, Beynon RJ, Simpson DM, Fraser HC, Hong Y, Hallang S, Stone TJ, Virasami A, Donson AM, Jones D, Aquilina K, Spoudeas H, Joshi AR, Grundy R, Storer LCD, Korbonits M, Hilton DA, Tossell K, Thavaraj S, Ungless MA, Gil J, Buslei R, Hankinson T, Hargrave D, Goding C, Andoniadou CL, Brogan P, Jacques TS, Williams HJ, Martinez-Barbera JP.

Acta Neuropathol. 2018 May;135(5):757-777. doi: 10.1007/s00401-018-1830-2. Epub 2018 Mar 14.

34.

An open-label trial of JAK 1/2 blockade in progressive IFIH1-associated neuroinflammation.

Kothur K, Bandodkar S, Chu S, Wienholt L, Johnson A, Barclay P, Brogan PA, Rice GI, Crow YJ, Dale RC.

Neurology. 2018 Feb 6;90(6):289-291. doi: 10.1212/WNL.0000000000004921. Epub 2018 Jan 10. No abstract available.

PMID:
29321238
35.

Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome.

Rowczenio DM, Pathak S, Arostegui JI, Mensa-Vilaro A, Omoyinmi E, Brogan P, Lipsker D, Scambler T, Owen R, Trojer H, Baginska A, Gillmore JD, Wechalekar AD, Lane T, Williams R, Youngstein T, Hawkins PN, Savic S, Lachmann HJ.

Blood. 2018 Mar 1;131(9):974-981. doi: 10.1182/blood-2017-10-810366. Epub 2017 Dec 28.

36.

Moyamoya-like cerebrovascular disease in a child with a novel mutation in myosin heavy chain 11.

Keylock A, Hong Y, Saunders D, Omoyinmi E, Mulhern C, Roebuck D, Brogan P, Ganesan V, Eleftheriou D.

Neurology. 2018 Jan 16;90(3):136-138. doi: 10.1212/WNL.0000000000004828. Epub 2017 Dec 20. No abstract available.

37.

Addison's disease presenting with perimyocarditis.

Lamback EB, Morandi G, Rapti E, Christov G, Brogan PA, Hindmarsh P.

J Pediatr Endocrinol Metab. 2018 Jan 26;31(1):101-105. doi: 10.1515/jpem-2017-0278.

PMID:
29252198
38.

Late-Onset Cryopyrin-Associated Periodic Syndromes Caused by Somatic NLRP3 Mosaicism-UK Single Center Experience.

Rowczenio DM, Gomes SM, Aróstegui JI, Mensa-Vilaro A, Omoyinmi E, Trojer H, Baginska A, Baroja-Mazo A, Pelegrin P, Savic S, Lane T, Williams R, Brogan P, Lachmann HJ, Hawkins PN.

Front Immunol. 2017 Oct 31;8:1410. doi: 10.3389/fimmu.2017.01410. eCollection 2017.

39.

Tocilizumab for the Treatment of SLC29A3 Mutation Positive PHID Syndrome.

Rafiq NK, Hussain K, Brogan PA.

Pediatrics. 2017 Nov;140(5). pii: e20163148. doi: 10.1542/peds.2016-3148.

40.

Shared decision-making at the end of life: A focus group study exploring the perceptions and experiences of multi-disciplinary healthcare professionals working in the home setting.

Brogan P, Hasson F, McIlfatrick S.

Palliat Med. 2018 Jan;32(1):123-132. doi: 10.1177/0269216317734434. Epub 2017 Oct 12.

PMID:
29020854
41.

European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.

Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Özen S, Pilkington CA, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert BJ, Wulffraat NM, Beresford MW, Kamphuis S.

Ann Rheum Dis. 2017 Dec;76(12):1965-1973. doi: 10.1136/annrheumdis-2017-211898. Epub 2017 Sep 6.

PMID:
28877866
42.

Vasculitis update: pathogenesis and biomarkers.

Brogan P, Eleftheriou D.

Pediatr Nephrol. 2018 Feb;33(2):187-198. doi: 10.1007/s00467-017-3597-4. Epub 2017 Aug 7. Review.

43.

Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.

Westwell-Roper C, Lubieniecka JM, Brown KL, Morishita KA, Mammen C, Wagner-Weiner L, Yen E, Li SC, O'Neil KM, Lapidus SK, Brogan P, Cimaz R, Cabral DA; for ARChiVe Investigators Network within the PedVas initiative.

Pediatr Rheumatol Online J. 2017 Aug 7;15(1):61. doi: 10.1186/s12969-017-0191-z.

44.

Clinical impact of a targeted next-generation sequencing gene panel for autoinflammation and vasculitis.

Omoyinmi E, Standing A, Keylock A, Price-Kuehne F, Melo Gomes S, Rowczenio D, Nanthapisal S, Cullup T, Nyanhete R, Ashton E, Murphy C, Clarke M, Ahlfors H, Jenkins L, Gilmour K, Eleftheriou D, Lachmann HJ, Hawkins PN, Klein N, Brogan PA.

PLoS One. 2017 Jul 27;12(7):e0181874. doi: 10.1371/journal.pone.0181874. eCollection 2017.

45.

European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative.

Groot N, de Graeff N, Avcin T, Bader-Meunier B, Brogan P, Dolezalova P, Feldman B, Kone-Paut I, Lahdenne P, Marks SD, McCann L, Ozen S, Pilkington C, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW.

Ann Rheum Dis. 2017 Nov;76(11):1788-1796. doi: 10.1136/annrheumdis-2016-210960. Epub 2017 Jun 19.

PMID:
28630236
46.

Microparticles in acute coronary syndrome.

Mavroudis CA, Eleftheriou D, Hong Y, Majumder B, Koganti S, Sapsford R, North J, Lowdell M, Klein N, Brogan P, Rakhit RD.

Thromb Res. 2017 Aug;156:109-116. doi: 10.1016/j.thromres.2017.06.003. Epub 2017 Jun 9.

PMID:
28624718
47.

De Novo PTEN Mutation in a Young Boy with Cutaneous Vasculitis.

Mauro A, Omoyinmi E, Sebire NJ, Barnicoat A, Brogan P.

Case Rep Pediatr. 2017;2017:9682803. doi: 10.1155/2017/9682803. Epub 2017 Apr 24.

48.

European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative.

Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman B, Kenet G, Koné-Paut I, Lahdenne P, Marks SD, McCann L, Pilkington CA, Ravelli A, van Royen-Kerkhof A, Uziel Y, Vastert SJ, Wulffraat NM, Ozen S, Brogan P, Kamphuis S, Beresford MW.

Ann Rheum Dis. 2017 Oct;76(10):1637-1641. doi: 10.1136/annrheumdis-2016-211001. Epub 2017 May 4. Review.

PMID:
28473426
49.

Microparticles and their role in coronary artery disease.

Koganti S, Eleftheriou D, Brogan PA, Kotecha T, Hong Y, Rakhit RD.

Int J Cardiol. 2017 Mar 1;230:339-345. doi: 10.1016/j.ijcard.2016.12.108. Epub 2016 Dec 22. Review.

PMID:
28040277
50.

Early-Onset Juvenile SLE Associated With a Novel Mutation in Protein Kinase C δ.

Nanthapisal S, Omoyinmi E, Murphy C, Standing A, Eisenhut M, Eleftheriou D, Brogan PA.

Pediatrics. 2017 Jan;139(1). pii: e20160781. doi: 10.1542/peds.2016-0781. Epub 2016 Dec 21.

Supplemental Content

Loading ...
Support Center